Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $512,928 - $731,664
1,600 Added 94.12%
3,300 $1.1 Million
Q2 2024

Aug 14, 2024

BUY
$372.0 - $424.34 $148,800 - $169,736
400 Added 30.77%
1,700 $700,000
Q1 2024

May 15, 2024

SELL
$284.87 - $413.31 $826,123 - $1.2 Million
-2,900 Reduced 69.05%
1,300 $525,000
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $955,584 - $1.31 Million
4,200 New
4,200 $1.29 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $333,288 - $514,344
-2,400 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $36,548 - $45,580
200 Added 9.09%
2,400 $526,000
Q3 2021

Nov 12, 2021

BUY
$170.18 - $198.21 $374,396 - $436,062
2,200 New
2,200 $413,000
Q1 2021

May 14, 2021

SELL
$132.02 - $168.26 $396,060 - $504,780
-3,000 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$109.38 - $149.19 $328,140 - $447,570
3,000 New
3,000 $414,000
Q2 2020

Aug 13, 2020

SELL
$68.08 - $95.68 $231,472 - $325,312
-3,400 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$61.71 - $101.95 $129,591 - $214,095
-2,100 Reduced 38.18%
3,400 $255,000
Q4 2019

Feb 12, 2020

SELL
$70.08 - $84.64 $322,368 - $389,344
-4,600 Reduced 45.54%
5,500 $458,000
Q3 2019

Nov 14, 2019

SELL
$62.38 - $85.89 $392,994 - $541,107
-6,300 Reduced 38.41%
10,100 $840,000
Q2 2019

Aug 20, 2019

SELL
$53.64 - $65.42 $702,684 - $857,002
-13,100 Reduced 44.41%
16,400 $1.07 Million
Q1 2019

May 15, 2019

BUY
$49.38 - $70.58 $1.11 Million - $1.59 Million
22,500 Added 321.43%
29,500 $1.74 Million
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $211,365 - $287,910
-4,500 Reduced 39.13%
7,000 $363,000
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $497,375 - $733,010
11,500 New
11,500 $689,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.